Latest Market Research Reports

  Smart Pills Market Summary The global  smart pills market  size was estimated at USD 1.7 billion in 2023 and is projected to reach USD 3.64 billion by 2030, growing at a CAGR of 11.3% from 2024 to 2030. Smart pills, also known as digital pills or ingestible sensors, are considered a significant innovation in healthcare, as they combine pharmaceuticals with digital monitoring technologies. This integration offers advanced capabilities for tracking patient health, monitoring treatment outcomes, and ensuring medication adherence, all of which play a crucial role in improving healthcare delivery and patient outcomes. Smart pills are equipped with miniature sensors that transmit data on how the body responds to medication intake. The information includes key indicators such as vital signs, digestive tract activity, or adherence to prescribed medication schedules. This data is then sent to external devices like smartphones, tablets, or computers, allowing both patients and he...

  The global smart pills market size was valued at USD 1.67 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.4% from 2023 to 2030. High demand for minimally invasive procedures, increased focus on patient convenience, and technological development, including miniaturization of integrated circuits, are factors that are expected to drive market growth. According to the National Center for Biotechnology Information (NCBI), over the course of 18 years, from 2000 to 2018, the U.S. witnessed a significant 50% increase in the number of minimally invasive procedures performed. In 2018 alone, the country recorded a remarkable total of over 15 million minimally invasive procedures. Among these procedures, laparoscopic cholecystectomy (gallbladder removal), appendectomy, and hernia repair are the most common ones. These minimally invasive techniques have gained popularity due to their numerous advantages over traditional open surgery. Gather more...